| Item Type | Name |
|
Concept
|
Antigens, Neoplasm
|
|
Concept
|
Antibodies, Neoplasm
|
|
Concept
|
Breast Neoplasms
|
|
Concept
|
Neoplasm Transplantation
|
|
Concept
|
Neoplasm Staging
|
|
Concept
|
Lung Neoplasms
|
|
Concept
|
Biomarkers, Tumor
|
|
Concept
|
Tumor Cells, Cultured
|
|
Concept
|
Central Nervous System Neoplasms
|
|
Concept
|
Lymphocytes, Tumor-Infiltrating
|
|
Concept
|
Meningeal Neoplasms
|
|
Concept
|
Neoplasm Metastasis
|
|
Concept
|
Neoplasms, Experimental
|
|
Concept
|
Gene Expression Regulation, Developmental
|
|
Concept
|
Tumor Burden
|
|
Concept
|
Tumor Escape
|
|
Concept
|
T-Lymphocytes, Regulatory
|
|
Concept
|
Tumor Microenvironment
|
|
Concept
|
Cell Line, Tumor
|
|
Concept
|
Brain Neoplasms
|
|
Concept
|
Neoplasm Proteins
|
|
Concept
|
Neoplasms
|
|
Academic Article
|
Phenotype of CD4+ T cell subsets that develop following mouse facial nerve axotomy.
|
|
Academic Article
|
Effects of facial nerve axotomy on Th2- and Th1-associated chemokine expression in the facial motor nucleus of wild-type and presymptomatic mSOD1 mice.
|
|
Academic Article
|
Reduced skin homing by functional Treg in vitiligo.
|
|
Academic Article
|
The presence of IL-17A and T helper 17 cells in experimental mouse brain tumors and human glioma.
|
|
Academic Article
|
Recent developments on immunotherapy for brain cancer.
|
|
Academic Article
|
Characterization and immunotherapeutic implications for a novel antibody targeting interleukin (IL)-13 receptor a2.
|
|
Academic Article
|
IDO expression in brain tumors increases the recruitment of regulatory T cells and negatively impacts survival.
|
|
Academic Article
|
Thymus-derived rather than tumor-induced regulatory T cells predominate in brain tumors.
|
|
Academic Article
|
Short hairpin RNA-mediated fibronectin knockdown delays tumor growth in a mouse glioma model.
|
|
Academic Article
|
The expression of BST2 in human and experimental mouse brain tumors.
|
|
Academic Article
|
Receptor tyrosine kinase signaling regulates different modes of Groucho-dependent control of Dorsal.
|
|
Academic Article
|
Blood-brain barrier permeable gold nanoparticles: an efficient delivery platform for enhanced malignant glioma therapy and imaging.
|
|
Academic Article
|
Heme oxygenase-1 protects regulatory T cells from hypoxia-induced cellular stress in an experimental mouse brain tumor model.
|
|
Academic Article
|
Nanoparticle-programmed self-destructive neural stem cells for glioblastoma targeting and therapy.
|
|
Academic Article
|
Depletion of myeloid-derived suppressor cells during interleukin-12 immunogene therapy does not confer a survival advantage in experimental malignant glioma.
|
|
Academic Article
|
Fibrin-binding, peptide amphiphile micelles for targeting glioblastoma.
|
|
Academic Article
|
Durable therapeutic efficacy utilizing combinatorial blockade against IDO, CTLA-4, and PD-L1 in mice with brain tumors.
|
|
Academic Article
|
Dendritic Cell-Based Vaccines that Utilize Myeloid Rather than Plasmacytoid Cells Offer a Superior Survival Advantage in Malignant Glioma.
|
|
Academic Article
|
The role of IDO in brain tumor immunotherapy.
|
|
Academic Article
|
The kynurenine to tryptophan ratio as a prognostic tool for glioblastoma patients enrolling in immunotherapy.
|
|
Academic Article
|
Molecular Pathways: Targeting IDO1 and Other Tryptophan Dioxygenases for Cancer Immunotherapy.
|
|
Academic Article
|
Updates from the Neuro-Oncology Section of the 2015 American Neurological Association Annual Meeting.
|
|
Academic Article
|
Functional cloning of a gp100-reactive T-cell receptor from vitiligo patient skin.
|
|
Academic Article
|
Tumor relapse prevented by combining adoptive T cell therapy with Salmonella typhimurium.
|
|
Academic Article
|
Advanced age negatively impacts survival in an experimental brain tumor model.
|
|
Academic Article
|
CCL2 Produced by the Glioma Microenvironment Is Essential for the Recruitment of Regulatory T Cells and Myeloid-Derived Suppressor Cells.
|
|
Academic Article
|
Differential actions of pituitary adenylyl cyclase-activating polypeptide and interferon gamma on Th2- and Th1-associated chemokine expression in cultured murine microglia.
|
|
Academic Article
|
Effects of facial nerve axotomy on Th2-associated and Th1-associated chemokine mRNA expression in the facial motor nucleus of wild-type and presymptomatic SOD1 mice.
|
|
Academic Article
|
Ménage à trois: Sustained therapeutic anti-tumor immunity requires multiple partners in malignant glioma.
|
|
Academic Article
|
Developmental therapeutics for patients with breast cancer and central nervous system metastasis: current landscape and future perspectives.
|
|
Academic Article
|
Non-tumor cell IDO1 predominantly contributes to enzyme activity and response to CTLA-4/PD-L1 inhibition in mouse glioblastoma.
|
|
Academic Article
|
Therapeutic Hypothesis Testing With Rodent Brain Tumor Models.
|
|
Academic Article
|
The Boosting Potential of Bacteria in Cancer Immunotherapy.
|
|
Academic Article
|
A Dendritic Cell-Targeted Adenoviral Vector Facilitates Adaptive Immune Response Against Human Glioma Antigen (CMV-IE) and Prolongs Survival in a Human Glioma Tumor Model.
|
|
Academic Article
|
Workshop on challenges, insights, and future directions for mouse and humanized models in cancer immunology and immunotherapy: a report from the associated programs of the 2016 annual meeting for the Society for Immunotherapy of cancer.
|
|
Academic Article
|
IDO1 Inhibition Synergizes with Radiation and PD-1 Blockade to Durably Increase Survival Against Advanced Glioblastoma.
|
|
Academic Article
|
IDO1 in cancer: a Gemini of immune checkpoints.
|
|
Academic Article
|
Imaging tryptophan uptake with positron emission tomography in glioblastoma patients treated with indoximod.
|
|
Academic Article
|
Infiltrating T Cells Increase IDO1 Expression in Glioblastoma and Contribute to Decreased Patient Survival.
|
|
Academic Article
|
Management of glioblastoma in elderly patients.
|
|
Academic Article
|
Newly Diagnosed Glioblastoma: A Review on Clinical Management.
|
|
Academic Article
|
The interplay among psychological distress, the immune system, and brain tumor patient outcomes.
|
|
Academic Article
|
CD73: an emerging checkpoint for cancer immunotherapy.
|
|
Academic Article
|
Antibody targeting tumor-derived soluble NKG2D ligand sMIC provides dual co-stimulation of CD8 T cells and enables sMIC+ tumors respond to PD1/PD-L1 blockade therapy.
|
|
Academic Article
|
Quantification of IDO1 enzyme activity in normal and malignant tissues.
|
|
Academic Article
|
Antibody targeting tumor-derived soluble NKG2D ligand sMIC reprograms NK cell homeostatic survival and function and enhances melanoma response to PDL1 blockade therapy.
|
|
Academic Article
|
Systematic Review of the Kynurenine Pathway and Psychoneurological Symptoms Among Adult Cancer Survivors.
|
|
Academic Article
|
Immunosuppressive IDO in Cancer: Mechanisms of Action, Animal Models, and Targeting Strategies.
|
|
Academic Article
|
Targeting CD73 to augment cancer immunotherapy.
|
|
Academic Article
|
The Impact of Beta Blockers on Survival Outcomes in Patients With Non-small-cell Lung Cancer Treated With Immune Checkpoint Inhibitors.
|
|
Academic Article
|
Unique challenges for glioblastoma immunotherapy-discussions across neuro-oncology and non-neuro-oncology experts in cancer immunology. Meeting Report from the 2019 SNO Immuno-Oncology Think Tank.
|
|
Academic Article
|
NK cell-based cancer immunotherapy: from basic biology to clinical development.
|
|
Academic Article
|
Tryptophan metabolism in brain tumors - IDO and beyond.
|
|
Academic Article
|
Tumor-derived NKG2D ligand sMIC reprograms NK cells to an inflammatory phenotype through CBM signalosome activation.
|
|
Academic Article
|
Tumor Cell IDO Enhances Immune Suppression and Decreases Survival Independent of Tryptophan Metabolism in Glioblastoma.
|
|
Academic Article
|
CD11c+CD163+ Cells and Signal Transducer and Activator of Transcription 3 (STAT3) Expression Are Common in Melanoma Leptomeningeal Disease.
|
|
Academic Article
|
Targeting glioblastoma signaling and metabolism with a re-purposed brain-penetrant drug.
|
|
Academic Article
|
Mid-life epigenetic age, neuroimaging brain age, and cognitive function: coronary artery risk development in young adults (CARDIA) study.
|
|
Academic Article
|
Circadian Regulator CLOCK Drives Immunosuppression in Glioblastoma.
|
|
Academic Article
|
Reshaping the tumor microenvironment with oncolytic viruses, positive regulation of the immune synapse, and blockade of the immunosuppressive oncometabolic circuitry.
|
|
Academic Article
|
Identification and Characterization of a Novel Indoleamine 2,3-Dioxygenase 1 Protein Degrader for Glioblastoma.
|
|
Grant
|
The role of IDO and Th17 in an experimental mouse model of glioma
|
|
Grant
|
The interaction of IDO and Tregs Leads to Immunosuppression in Glioma
|
|
Grant
|
The interaction of IDO and Tregs Leads to Immunosuppression in Glioma
|
|
Grant
|
Aging, immunosenescence and glioblastoma
|
|
Academic Article
|
Advanced Age in Humans and Mouse Models of Glioblastoma Show Decreased Survival from Extratumoral Influence.
|
|
Academic Article
|
Lactate dehydrogenase A regulates tumor-macrophage symbiosis to promote glioblastoma progression.
|
|
Academic Article
|
LDHA-regulated tumor-macrophage symbiosis promotes glioblastoma progression.
|